Brian Mann

Copyright 2021 NPR. To see more, visit https://www.npr.org.

DAVID GREENE, HOST:

Updated at 1:22 p.m. ET

Members of the Sackler family and Purdue Pharma's CEO say they did nothing wrong during the years their company illegally marketed Oxycontin and other opioids.

"There's nothing I can find that I would have done differently," said Dr. Kathe Sackler who served on Purdue's board for nearly 20 years.

One of the world's most influential corporate consulting firms, McKinsey & Company, says it regrets efforts to boost sales of OxyContin and other highly addictive opioids.

The rare apology follows revelations in documents made public last month for the first time that showed McKinsey working closely with Purdue Pharma and members of the Sackler family who sat on Purdue's board.

Updated at 7:20 p.m. ET

Newly public documents paint a detailed and often damning portrait of the role played by members of the Sackler family, owners of Purdue Pharma, during years when the privately owned drug company launched criminal schemes designed to "turbocharge" sales of Oxycontin and other highly addictive opioid medications.

A new rule that took effect this year in New York state is designed to stop the illegal sale of black bear parts for use in Asian medicine and cooking. While the sale of parts is still allowed, hunters will now have to document that they were taken legally.

The tiny village of Keene, N.Y., in the Adirondack Mountains is part of a trade network that supplies Asian apothecaries and restaurants from New York City to Seoul, South Korea.

Pages